Tumor immunotherapy by epicutaneous immunization requires langerhans cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
Patrizia StoitznerFranca Ronchese

Abstract

A role for Langerhans cells (LC) in the induction of immune responses in the skin has yet to be conclusively demonstrated. We used skin immunization with OVA protein to induce immune responses against OVA-expressing melanoma cells. Mice injected with OVA-specific CD8(+) T cells and immunized with OVA onto barrier-disrupted skin had increased numbers of CD8(+) T cells in the blood that produced IFN-gamma and killed target cells. These mice generated accelerated cytotoxic responses after secondary immunization with OVA. Prophylactic or therapeutic immunization with OVA onto barrier-disrupted skin inhibited the growth of B16.OVA tumors. LC played a critical role in the immunization process because depletion of LC at the time of skin immunization dramatically reduced the tumor-protective effect. The topically applied Ag was presented by skin-derived LC in draining lymph nodes to CD8(+) T cells. Thus, targeting of tumor Ags to LC in vivo is an effective strategy for tumor immunotherapy.

References

Mar 1, 1985·The Journal of Experimental Medicine·G Schuler, R M Steinman
Jul 17, 1995·Journal of Immunological Methods·A D McLellanD N Hart
Jan 14, 1994·Cell·K A HogquistF R Carbone
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·N SeoM Takigawa
Jan 5, 2000·The Journal of Investigative Dermatology·H SuzukiD N Sauder
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A L MarzoB Scott
Mar 14, 2003·Current Opinion in Immunology·Gerold SchulerRalph M Steinman
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ian F HermansVincenzo Cerundolo
Feb 14, 2004·The Journal of Investigative Dermatology·Hiroshi MitsuiKunihiko Tamaki
May 14, 2004·The Journal of Investigative Dermatology·Sandra HolzmannNikolaus Romani
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gerd RechtsteinerMarkus P Radsak
May 18, 2005·The Journal of Cell Biology·Clare L BennettBjörn E Clausen
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amit A LugadeEdith M Lord
Jun 29, 2005·The Journal of Investigative Dermatology·Patrizia StoitznerNikolaus Romani
Dec 17, 2005·Immunity·Daniel H KaplanMark J Shlomchik
Mar 23, 2006·Annual Review of Immunology·Thierry BoonPierre van der Bruggen
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Patrizia StoitznerNikolaus Romani
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincent FlacherJenny Valladeau
Feb 27, 2007·Immunology Letters·Tobias WargerGerd Rechtsteiner

❮ Previous
Next ❯

Citations

Nov 7, 2008·Blood·Catherine E AngelP Rod Dunbar
Mar 19, 2008·Immunology and Cell Biology·Frederick MassonGabrielle T Belz
Jun 28, 2008·Cancer Immunology, Immunotherapy : CII·Christina Stoeckle, Anne-Kathrin Gleske
Nov 11, 2008·European Journal of Immunology·Eduardo J Villablanca, Jorge R Mora
Apr 2, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karina FurmanovAvi-Hai Hovav
Mar 31, 2010·Immunology and Cell Biology·Björn E Clausen, Junda M Kel
Jul 20, 2010·Immunotherapy·Karsten A Pilones, Sandra Demaria
Feb 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincent FlacherNikolaus Romani
Nov 12, 2015·Frontiers in Immunology·Björn E Clausen, Patrizia Stoitzner
Jul 13, 2018·Frontiers in Immunology·Laura GornatiFrancesca Granucci
Aug 8, 2020·Frontiers in Cell and Developmental Biology·Rui-Jun Eveline LiYvette van Kooyk
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christoph H TrippPatrizia Stoitzner
Apr 7, 2010·Immunology and Cell Biology·Nikolaus RomaniVincent Flacher
Mar 17, 2010·Immunology and Cell Biology·Botond Z Igyarto, Daniel H Kaplan
Aug 5, 2008·Cancer Immunology, Immunotherapy : CII·Vincent FlacherPatrizia Stoitzner
Jun 28, 2012·Clinical & Experimental Metastasis·Gianni GerliniLorenzo Borgognoni
Oct 6, 2012·Therapeutic Delivery·Kenneth C McCulloughNicolas Ruggli
Apr 6, 2012·Expert Opinion on Drug Delivery·Sharifa Al-ZahraniRyan F Donnelly
Jul 12, 2013·Cancer Biotherapy & Radiopharmaceuticals·Armando Pérez-TorresDaniel Estrada-Bárcenas
Aug 17, 2016·Biotechnology Journal·Momoko KitaokaMasahiro Goto
Nov 4, 2017·Contrast Media & Molecular Imaging·Biliana TodorovaCatherine Chapon
Mar 3, 2010·Immunological Reviews·Nikolaus RomaniPatrizia Stoitzner
Mar 31, 2010·Immunology and Cell Biology·Patrizia StoitznerChristoph H Tripp
Dec 29, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angelika StoecklingerPeter Hammerl
Nov 26, 2008·Nature Reviews. Immunology·Miriam MeradMatthew Collin
Apr 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincent DioszeghyChristophe Dupont
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Irlanda Olvera-GomezStephen C Jameson
Apr 23, 2013·Clinical & Developmental Immunology·Valerie R YanofskyJohn A Carucci
Jul 10, 2009·Carcinogenesis·Atsushi TokurikiYoshifumi Yokota
Jun 5, 2015·Frontiers in Immunology·Soledad Mac KeonRosa Wainstok
Apr 24, 2012·Current Opinion in Immunology·Carl R AlvingSteven G Reed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.